FDA.reportPublic FDA data

ERY-TAB

Product NDC
68151-1174
11-digit product format
681511174
Labeler code
68151
Product ID
68151-1174_a613594f-d5fe-4e88-9049-2b21824a061d
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Erythromycin
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
Labeler
Carilion Materials Management
Application
ANDA062298
Marketing category
ANDA
Marketing start
2011-04-18
Marketing end
0000-00-00
Substance
ERYTHROMYCIN
Active strength
333 mg/1
Pharmacologic classes
Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [CS]
NDC exclude flag
E
Listing certified through
2018-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d329c2e1-5ae8-4e64-aea0-77ecea3fa1abProduct name320250717
3b331500-3b74-bd2b-fede-d46839f2f4d5Product name620240313
fdae2630-eae0-4769-abfd-8f33d5b771b4Product name320240202
8c898317-b543-1e4e-254f-84cec2f3f57eProduct name220191002
64ae94c0-3212-d73a-92da-9e6dd85c6ebeProduct name220180118
edcfa1cf-915f-1a4c-d0aa-508cc66e70d9Product name220170816
ad75fcfd-a339-42a1-9c60-43ba2c654cfaProduct name120170810
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
57850177-5927-151f-e1fa-7e2ca47f81e5Product name120140508
8ee71591-1d8f-e24e-242b-bfef131e3168Product name120140508
bff5cf99-0f45-fa15-2a76-b160c3c4cc3cProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
68151-1174-12020-01-31C16284748780-19d75b9d0-a08a-f424-e053-dadaa90a57ceERY-TAB (ERYTHROMYCIN DELAYED-RELEASE TABLETS, USP) ENTERIC-COATED ®

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
68151-1174-1ERY-TAB1 in 1 PACKAGETABLET, DELAYED RELEASE12

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ErythromycinACTIVE INGREDIENT63937KV33DERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]2
ErythromycinACTIVE MOIETY63937KV33DERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]2
AMMONIAINACTIVE INGREDIENT5138Q19F1XERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]2
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]2
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]2
CROSPOVIDONEINACTIVE INGREDIENT68401960MKERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]2
DIACETYLATED MONOGLYCERIDESINACTIVE INGREDIENT5Z17386USFERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]2
HYDROXYPROPYL CELLULOSE (TYPE H)INACTIVE INGREDIENTRFW2ET671PERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]2
HYPROMELLOSE PHTHALATE (24% PHTHALATE, 55 CST)INACTIVE INGREDIENT87Y6436BKRERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]2
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]2
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]2
POVIDONESINACTIVE INGREDIENTFZ989GH94EERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]2
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]2
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]2
SODIUM CITRATEINACTIVE INGREDIENT1Q73Q2JULRERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]2
SORBITAN MONOOLEATEINACTIVE INGREDIENT06XEA2VD56ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]2
TALCINACTIVE INGREDIENT7SEV7J4R1UERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]2
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
68151-1174ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT]2Legacy NDC, 1 package rows20140828_83b88647-1b7c-444f-ab20-cdb5afd265bf.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
206078ERY-TAB 333 MG Delayed Release Oral TabletPSN83b88647-1b7c-444f-ab20-cdb5afd265bf2
315090erythromycin 333 MG Delayed Release Oral TabletPSN83b88647-1b7c-444f-ab20-cdb5afd265bf2
206078erythromycin 333 MG Delayed Release Oral Tablet [Ery-Tab]SBD83b88647-1b7c-444f-ab20-cdb5afd265bf2
315090erythromycin 333 MG Delayed Release Oral TabletSCD83b88647-1b7c-444f-ab20-cdb5afd265bf2
206078Ery-Tab 333 MG Delayed Release Oral TabletSY83b88647-1b7c-444f-ab20-cdb5afd265bf2

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionStatus
68151-1174-1681511174011 in 1 PACKAGEHistorical